Showing results (821-830 of 1,995) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|November 16, 2013
Axonal Guillain-Barré syndrome: concepts and controversiesSatoshi Kuwabara, Nobuhiro Yuki
The Lancet. Neurology|October 22, 2013
Advancing care for traumatic brain injury: findings from the IMPACT studies and perspectives on future researchAndrew I R Maas, Gordon D Murray, Bob Roozenbeek, et al.
The Lancet. Neurology|October 1, 2013
Brain banking for neurological disordersNeshika Samarasekera, Rustam Al-Shahi Salman, Inge Huitinga, et al.
The Lancet. Neurology|October 11, 2013
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trialYves Dauvilliers, Claudio Bassetti, Gert Jan Lammers, et al.
The Lancet. Neurology|January 10, 2012
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trialDavid H Miller, Thomas Weber, Richard Grove, et al.
The Lancet. Neurology|March 13, 2012
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyElisa Majounie, Alan E Renton, Kin Mok, et al.
The Lancet. Neurology|January 3, 2015
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trialSubha V Raman, Kan N Hor, Wojciech Mazur, et al.
The Lancet. Neurology|December 3, 2014
Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational studyJane S Paulsen, Jeffrey D Long, Christopher A Ross, et al.
The Lancet. Neurology|July 28, 2015
Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directionsSandrine Andrieu, Nicola Coley, Simon Lovestone, et al.
The Lancet. Neurology|December 15, 2015
Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient dataMargaret A Horne, Kelly D Flemming, I-Chang Su, et al.
Pageof 200